header shadow

Dr. Peter Nara, Co-Director

 
  
   Dr. Peter Nara, Co-Director
 
 
     Dr. Nara is currently the newly appointed Endowed Eugene Lloyd Chair, Professor and founding Center Director for the Center for Advanced Host Defense, Immunobiotics, and Translational Comparative Medicine in the Department of Biomedical Sciences, in the College of Veterinary Medicine at Iowa State University. 
 
     He is also the Chief Executive Officer, President, Chairman & co-founder of Biological Mimetics, Inc., a biotechnology company founded to translate the theory of “Deceptive Imprinting” and the “Immune Refocusing” Technology, discovered by Dr. Nara and colleagues, into preventative vaccines, novel immuno-therapeutics and diagnostics in both human and veterinary medicine. Prior to this position, Dr. Nara was formerly the Section Chief of the Vaccine Resistant Diseases Section, Division of Basic Sciences, Office of the Director at the National Cancer Institute, National Institutes of Health.
 
     Dr Nara’s scientific contributions include to date over 21 book chapters and 173 scientifically peer-reviewed publications.  Some highlights include: his laboratory at the National Cancer Institute was designated both a National and International AIDS Reference Laboratory by the National Institute’s of Allergy and Infectious Diseases and World Health Organization (WHO), Global Program on AIDS; he initiated a International effort which characterized over 120 HIV-1 isolates for future vaccine and clinical trial site development from epidemic centers around the world, his laboratory was designated the first of five  HIV-1 Immunotyping laboratories, Group leader and chairman for the WHO Network for HIV Isolation and Characterization.
 
     He is a regular member of the National Academy of Science, Institutes of Medicine, National Institutes of Health, Department of Defense, and Centers for Disease Control AIDS–related and infectious diseases national planning, human and animal agricultural Biodefense, vaccine development & policy reporting meetings involving pathogenesis, vaccine discovery, standardization, correlates of protection committees and consults and serves on numerous scientific advisory boards of corporate, private foundations and academic initiatives in the area of national biodefense, comparative medicine and immunology, vaccine discovery and immuno-therapeutics and a recent member of the U.S. State Department BioIndustry Initiative Program, The civilian Research and Development Foundation (CDRF) and The International Science and Technology Center (ISTC) for non-proliferation of biological agents.
 
     He was a Howard Hughes, Ciba Corning, and Miles Invited Lecturer, nominated by Dr. Jonas Salk, elected, and served as Founding President of the International Society for Vaccines 1994-2002, he was the founding conference chairman and continues as the senior chairman for the Annual Conference on Vaccine Research (now in its 12th year, served on the editorial boards of the leading virology, AIDS, vaccine, immunology, comparative microbiology and pathogenesis  journals, and is the inventor or co-inventor on 7 issued U.S. patents. In 2009 he received the Order of the Knoll Medal from ISU, in 2007 was nominated as Biotechnology Executive of the Year in Frederick, County, Maryland and in 2008 Biological Mimetics, Inc. the biotechnology company co-founded by him was a finalist as small firm of the year by the State of Maryland Technology Council. In 2007 he was nominated and sits on the board of the prestigious National Foundations for Infectious Diseases in Washington D.C.